{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=MiMedx%20Group%2C%20Inc.","name":"MiMedx Group, Inc.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-03T23:43:17.298Z"},"count":1,"matches":[{"id":"49abbc233ecbeecd","posted_date":"2024-01-09","letter_issue_date":"2023-12-20","company_name":"MiMedx Group, Inc.","issuing_office":"Center for Biologics Evaluation and Research (CBER)","subject":"Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)","canonical_url":"https://api.morvs.ai/fda-warning/49abbc233ecbeecd"}]}